Submit Deal

VENROCK HEALTHCARE CAPITAL PARTNERS

HQ - London

Summary

Venrock Healthcare Capital Partners is a fund dedicated to investing in publicly-held and privately-held healthcare companies

Deals Overview

Total Deals11

Valued Deals9

Total Value£ 1.40 B

Avg. Deal Size£ 156 M

Market Context

Senior Management

Brian Ascher
Partner
Alex Rosen
Managing Director and Partner
Andrew Gottesdiener
Partner

Sort

17 May 2021|United States|Pharmaceuticals

Target: AADI BIOSCIENCE INC

Bidder: AERPIO PHARMACEUTICALS INC

22 Service Providers

4 Target | 18 Bidder

44 Dealmakers

23 Target | 21 Bidder

n/a

Value

02 Nov 2022|United States|Biotechnology

Target: LUSARIS THERAPEUTICS

Bidder: VENROCK HEALTHCARE CAPITAL PARTNERS

7 Service Providers

3 Target | 4 Bidder

7 Dealmakers

3 Target | 4 Bidder

£ 52 M

Value

07 Dec 2022|United States|Biotechnology

Target: APOGEE THERAPEUTICS

Bidder: PERCEPTIVE ADVISORS LLC

3 Service Providers

2 Target | 1 Bidder

3 Dealmakers

2 Target | 1 Bidder

£ 122 M

Value

08 Jun 2023|United States|Biotechnology

Target: UPSTREAM BIO

Bidder: ALTSHULER SHAHAM

5 Service Providers

2 Target | 3 Bidder

5 Dealmakers

3 Target | 2 Bidder

£ 160 M

Value

09 Aug 2023|United States|Biotechnology

Target: ADARX PHARMACEUTICALS

Bidder: BAIN CAPITAL LIFE SCIENCES

3 Service Providers

1 Target | 2 Bidder

4 Dealmakers

2 Target | 2 Bidder

£ 156 M

Value

25 May 2023|United States|Biotechnology

Target: CARMOT THERAPEUTICS

Bidder: DEEP TRACK CAPITAL

12 Service Providers

2 Target | 10 Bidder

18 Dealmakers

1 Target | 17 Bidder

£ 120 M

Value

14 Feb 2024|United States|Biotechnology

Target: COGENT BIOSCIENCES

Bidder: REDMILE GROUP

5 Service Providers

5 Target

3 Dealmakers

3 Target

£ 284 M

Value

21 Mar 2024|United States|Pharmaceuticals

Target: MIRADOR THERAPEUTICS

Bidder: ORBIMED ADVISORS LLC

4 Service Providers

3 Target | 1 Bidder

7 Dealmakers

6 Target | 1 Bidder

£ 314 M

Value

13 May 2024|United States|Biotechnology

Target: LYCIA THERAPEUTICS

Bidder: JANUS HENDERSON INVESTORS

3 Service Providers

2 Target | 1 Bidder

3 Dealmakers

2 Target | 1 Bidder

£ 85 M

Value

31 Oct 2024|United States|Biotechnology

Target: AEROVATE THERAPEUTICS

Bidder: VENROCK HEALTHCARE CAPITAL PARTNERS

11 Service Providers

4 Target | 7 Bidder

5 Dealmakers

1 Target | 4 Bidder

n/a

Value

25 Nov 2024|Denmark|Biotechnology

Target: ADCENDO APS

Bidder: TPG CAPITAL LP

10 Service Providers

2 Target | 8 Bidder

12 Dealmakers

5 Target | 7 Bidder

£ 107 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy